Association of subjective cognitive dysfunction with akathisia in patients receiving stable doses of risperidone or haloperidol

Journal of Clinical Pharmacy and Therapeutics

Volumn 32, Issue 5, 2007, Pages 461-467

  Kim, Jong Hoon ^a   Byun, Hee Jung ^b  

^a Gachon University   (South Korea)

^b Seoul Children's Hospital   (South Korea)

Author keywords

Akathisia; Antipsychotics; Subjective cognitive dysfunction

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; HALOPERIDOL; RISPERIDONE;

ADULT; AKATHISIA; ANALYSIS OF COVARIANCE; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ASSESSMENT; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; COPING BEHAVIOR; DISEASE ASSOCIATION; DISEASE SEVERITY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PARKINSONISM; PERCEPTION DISORDER; PERCEPTIVE DISCRIMINATION; QUESTIONNAIRE; RATING SCALE; SCHIZOPHRENIA; SCORING SYSTEM; SELECTIVE ATTENTION; STATISTICAL SIGNIFICANCE;

ADULT; AKATHISIA, DRUG-INDUCED; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; COGNITION DISORDERS; FEMALE; HALOPERIDOL; HUMANS; MALE; PSYCHOMETRICS; QUESTIONNAIRES; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

EID: 34548641700     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2007.00848.x     Document Type: Article

References (34)

1. Adler LA, Angrist B, Reiter S, Rotrosen J (1989) Neuroleptic-induced akathisia: a review. Psychopharmacology, 97, 1 11.
2. Hansen L, Kingdom D (2006) Akathisia as a risk factor for suicide. British Journal of Psychiatry, 188, 192.
3. Hansen L (2001) A critical review of akathisia, and its possible association with suicidal behaviour. Human Psychopharmacology, 16, 495 505.
4. Ayd FJ Jr. (1961) A survey of drug-induced extrapyramidal reactions. Journal of the American Medical Association, 175, 1054 1060.
5. Van Putten T, Marder SR (1987) Behavioral toxicity of antipsychotic drugs. Journal of Clinical Psychiatry, 48 (Suppl. 13 19.
6. Newcomer JW, Miller LS, Faustman WO, Wetzel MW, Vogler GP, Csernansky JG (1994) Correlations between akathisia and residual psychopathology: a by-product of neuroleptic-induced dysphoria. British Journal of Psychiatry, 164, 834 838.
7. Dech H, Northoff G (1997) The symptomology of akathisia. Fortschritte der Neurologie-Psychiatrie, 65, 232 236.
8. Raskin DE (1985) Antipsychotic medication and the elderly. Journal of Clinical Psychiatry, 46, 36 40.
9. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders (DSM-IV), 4th edn. Washington, DC: American Psychiatric Association.
10. Barnes TR (1989) A rating scale for drug-induced akathisia. British Journal of Psychiatry, 154, 672 676.
11. Halstead SM, Barnes TRE, Speller JC (1994) Akathisia: prevalence and associated dysphoria in an in-patient population with chronic schizophrenia. British Journal of Psychiatry, 164, 177 183.
12. Nair CJ, Josiassen RC, Abraham G, Stanilla JK, Tracy JI, Simpson GM (1999) Does akathisia influence psychopathology in psychotic patients treated with clozapine? Biological Psychiatry, 45, 1376 1383.
13. Simpson GM, Angus JW (1970) A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica Supplementum, 212, 11 19.
14. Guy W (1976) ECDEU assessment manual for psychopharmacology. Publication ADM 76-338. Washington, DC: US Department of Health, Education and Welfare, 534 537.
15. Schooler NR, Kane JM (1982) Research diagnoses for tardive dyskinesia. Archives of General Psychiatry, 39, 486 487.
16. Süllwold L (1977) Symptome schizophrener Erkrankungen: Uncharakteristische Basisstörungen. Berlin, Heidelberg, New York: Springer.
17. Chang HI, Kim JK, Yum TH et al. (1995) Manual of Kyung Hee Frankfurt Beschwerde Fragebogen. Journal of Korean Neuropsychiatric Association, 34, 754 771.
18. Cuesta MJ, Peralta V, Juan JA (1996) Abnormal subjective experiences in schizophrenia: its relationships with neuropsychological disturbances and frontal signs. European Archives of Psychiatry and Clinical Neuroscience, 246, 101 105.
19. Krawiecka M, Goldberg D, Vaughan M (1977) A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatrica Scandinavica, 55, 299 308.
20. Kim JH, Jung HY, Kang UG et al. (2002) Metric characteristics of the DIEPSS: a practical combined rating scale for drug-induced movement disorders. Movement Disorders, 17, 1354 1359.
21. Parasuraman R, Davis DR (1984) Varieties of attention. Orlando: Academic Press.
22. Mathalon DH, Heinks T, Ford JM (2004) Selective attention in schizophrenia: sparing and loss of executive control. American Journal of Psychiatry, 161, 872 881.
23. Insel TR, Fernald RD (2004) How the brain processes social information: searching for the social brain. Annual Review of Neuroscience, 27, 697 722.
24. Rosebush PI, Mazurek MF (1999) Neurologic side effects in neuroleptic-naive patients treated with haloperidol or risperidone. Neurology, 52, 782 785.
25. Weiden PJ (2007) EPS profiles: the atypical antipsychotics are not all the same. Journal of Psychiatric Practice, 13, 13 24.
26. Gerlach J, Larsen EB (1999) Subjective experience and mental side-effects of antipsychotic treatment. Acta Psychiatrica Scandinavica Supplementum, 395, 113 117.
27. Krausz M, Moritz S, Lambert M, Naber D (2000) Dosage of conventional neuroleptic medication and subjective cognitive functioning in schizophrenia. International Clinical Psychopharmacology, 15, 77 81.
28. Prouteau A, Verdoux H, Briand C et al. (2004) Self-assessed cognitive dysfunction and objective performance in outpatients with schizophrenia participating in a rehabilitation program. Schizophrenia Research, 69, 85 91.
29. Naber D, Karow A (2001) Good tolerability equals good results: the patient's perspective. European Neuropsychopharmacology, 11 (Suppl. 4 391 396.
30. Voruganti LN, Awad AG (2002) Personal evaluation of transitions in treatment (PETiT): a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia. Schizophrenia Research, 56, 37 46.
31. Hofer A, Rettenbacher MA, Widschwendter CG, Kemmler G, Hummer M, Fleischhacker WW (2006) Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder. European Archives of Psychiatry and Clinical Neuroscience, 256, 246 255.
32. Cem Atbasoglu E, Schultz SK, Andreasen NC (2001) The relationship of akathisia with suicidality and depersonalization among patients with schizophrenia. Journal of Neuropsychiatry and Clinical Neurosciences, 13, 336 341.
33. De Oliveira IR, Juruena MF (2006) Treatment of psychosis: 30 years of progress. Journal of Clinical Pharmacy and Therapeutics, 31, 523 534.
34. Sachdev P, Hume F, Toohey P, Doutney C (1996) Negative symptoms, cognitive dysfunction, tardive akathisia and tardive dyskinesia. Acta Psychiatrica Scandinavica, 93, 451 459.